Literature DB >> 24273184

HIV-1 drug-resistant minority variants: sweating the small stuff.

Jonathan Z Li1.   

Abstract

Entities:  

Keywords:  HIV; minority variants; virologic failure

Mesh：

Substances：

Year:  2013        PMID： 24273184      PMCID： PMC3923546          DOI： 10.1093/infdis/jit656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  28 in total

1.  High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

Authors:  Charlotte Charpentier; Didier Laureillard; Christophe Piketty; Pascaline Tisserand; Dominique Batisse; Marina Karmochkine; Ali Si-Mohamed; Laurence Weiss
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

2.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

3.  Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.

Authors:  Jessica D Church; Dana Jones; Tamara Flys; Donald Hoover; Natalia Marlowe; Shu Chen; Chanjuan Shi; James R Eshleman; Laura A Guay; J Brooks Jackson; Newton Kumwenda; Taha E Taha; Susan H Eshleman
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

4.  Fidelity of HIV-1 reverse transcriptase.

Authors:  B D Preston; B J Poiesz; L A Loeb
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

5.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

6.  Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Lynn Morris; Neil Martinson; Glenda Gray; James McIntyre; Walid Heneine
Journal:  J Infect Dis       Date:  2005-06-01       Impact factor: 5.226

7.  Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

Authors:  Ashraf Coovadia; Gillian Hunt; Elaine J Abrams; Gayle Sherman; Tammy Meyers; Gill Barry; Eloise Malan; Belinda Marais; Renate Stehlau; Johanna Ledwaba; Scott M Hammer; Lynn Morris; Louise Kuhn
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

8.  In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.

Authors:  Athe M N Tsibris; Manish Sagar; Roy M Gulick; Zhaohui Su; Michael Hughes; Wayne Greaves; Mani Subramanian; Charles Flexner; Françoise Giguel; Kay E Leopold; Eoin Coakley; Daniel R Kuritzkes
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.

Authors:  Athe M N Tsibris; Bette Korber; Ramy Arnaout; Carsten Russ; Chien-Chi Lo; Thomas Leitner; Brian Gaschen; James Theiler; Roger Paredes; Zhaohui Su; Michael D Hughes; Roy M Gulick; Wayne Greaves; Eoin Coakley; Charles Flexner; Chad Nusbaum; Daniel R Kuritzkes
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240
View more
  5 in total

1.  Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing.

Authors:  Philip L Tzou; Pramila Ariyaratne; Vici Varghese; Charlie Lee; Elian Rakhmanaliev; Carolin Villy; Meiqi Yee; Kevin Tan; Gerd Michel; Benjamin A Pinsky; Robert W Shafer
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

2.  HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.

Authors:  H R Lapointe; W Dong; G Q Lee; D R Bangsberg; J N Martin; A R Mocello; Y Boum; A Karakas; D Kirkby; A F Y Poon; P R Harrigan; C J Brumme
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

3.  Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction.

Authors:  Jean L Mbisa; Peter Kirwan; Anna Tostevin; Juan Ledesma; David F Bibby; Alison Brown; Richard Myers; Amin S Hassan; Gary Murphy; David Asboe; Anton Pozniak; Stuart Kirk; O Noel Gill; Caroline Sabin; Valerie Delpech; David T Dunn
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

4.  Towards Better Precision Medicine: PacBio Single-Molecule Long Reads Resolve the Interpretation of HIV Drug Resistant Mutation Profiles at Explicit Quasispecies (Haplotype) Level.

Authors:  Da Wei Huang; Castle Raley; Min Kang Jiang; Xin Zheng; Dun Liang; M Tauseef Rehman; Helene C Highbarger; Xiaoli Jiao; Brad Sherman; Liang Ma; Xiaofeng Chen; Thomas Skelly; Jennifer Troyer; Robert Stephens; Tomozumi Imamichi; Alice Pau; Richard A Lempicki; Bao Tran; Dwight Nissley; H Clifford Lane; Robin L Dewar
Journal:  J Data Mining Genomics Proteomics       Date:  2015-11-08

5.  Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.

Authors:  Ronit R Dalmat; Negar Makhsous; Gregory G Pepper; Amalia Magaret; Keith R Jerome; Anna Wald; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.